Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease

Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease

Overnutrition and modern diets containing high proportions of saturated fat are among the major factors contributing to a low-grade state of inflammation, hyperglycemia and dyslipidemia. In the last decades, the global rise of type 2 diabetes and obesity prevalence has elicited a great interest in u...

Full description

Bibliographic Details
Main Authors:	Angeles Vinuesa, Carlos Pomilio, Amal Gregosa, Melisa Bentivegna, Jessica Presa, Melina Bellotto, Flavia Saravia, Juan Beauquis
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Neuroscience
Subjects:	Alzheimer’s disease metabolic disorders cognitive impairment insulin resistance inflammation therapies
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2021.653651/full

Similar Items

Periodic dietary restriction ameliorates amyloid pathology and cognitive impairment in PDAPP-J20 mice: Potential implication of glial autophagy
by: Amal Gregosa, et al.
Published: (2019-12-01)

Insulin resistance and reduced brain glucose metabolism in the aetiology of Alzheimer’s disease
by: Amy L. Berger
Published: (2016-12-01)

The Rationale for Insulin Therapy in Alzheimer’s Disease
by: Samo Ribarič
Published: (2016-05-01)

Insulin and Insulin Resistance in Alzheimer’s Disease
by: Aleksandra Sędzikowska, et al.
Published: (2021-09-01)

Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer’s Disease
by: Anna Litwiniuk, et al.
Published: (2021-05-01)

Insulin and insulin-like growth factor prevent brain atrophy and cognitive impairment in diabetic rats
by: Predrag Šerbedzija, et al.
Published: (2012-01-01)

Short-term environmental enrichment enhances adult neurogenesis, vascular network and dendritic complexity in the hippocampus of type 1 diabetic mice.
by: Juan Beauquis, et al.
Published: (2010-01-01)

Insulin Resistance in Alzheimer's Disease
by: Laís S. S. Ferreira, et al.
Published: (2018-11-01)

The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia
by: Jaume Folch, et al.
Published: (2018-01-01)

Vasculo-Neuronal Coupling and Neurovascular Coupling at the Neurovascular Unit: Impact of Hypertension
by: Jessica L. Presa, et al.
Published: (2020-09-01)

Intranasal Insulin Prevents Anesthesia-Induced Cognitive Impairment and Chronic Neurobehavioral Changes
by: Yanxing Chen, et al.
Published: (2017-05-01)

Aberrant insulin signaling in Alzheimer’s disease: current knowledge
by: Gaurav eBedse, et al.
Published: (2015-06-01)

Insulin resistance in Alzheimer's disease
by: Kelly T. Dineley, et al.
Published: (2014-12-01)

The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease
by: Bhumsoo Kim, et al.
Published: (2019-12-01)

Changes in gene expression of brain insulin system in STZ icv - damaged rats - relevance to Alzheimer disease
by: Osmanovic, Jelena
Published: (2008)

Mechanisms linking brain insulin resistance to Alzheimer's disease
by: Maria Niures P.S. Matioli, et al.

Distinguishing normal brain aging from the development of Alzheimer's disease: inflammation, insulin signaling and cognition
by: Paul Denver, et al.
Published: (2018-01-01)

Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
by: Zenghui Wei, et al.
Published: (2021-07-01)

INSULIN IN THE BRAIN: ITS PATHOPHYSIOLOGICAL IMPLICATIONS FOR STATES RELATED WITH CENTRAL INSULIN RESISTANCE, TYPE 2 DIABETES AND ALZHEIMER’S DISEASE
by: ENRIQUE eBLÁZQUEZ, et al.
Published: (2014-10-01)

Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
by: Antonella Tramutola, et al.
Published: (2020-04-01)

Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages
by: Bryan J. Neth, et al.
Published: (2017-10-01)

Serum insulin-like growth factor 1 (IGF-1) in multiple sclerosis: relation to cognitive impairment and fatigue
by: Rania S. Nageeb, et al.
Published: (2018-09-01)

Progress on the visual dysfunction after Alzheimer's disease and its mechanism
by: Qing Sang, et al.
Published: (2018-06-01)

Insulin, Cholesterol and A-beta: Roles and Mechanisms in Alzheimer’s disease
by: Najem, Dema
Published: (2014)

Insulin, Cholesterol and A-beta: Roles and Mechanisms in Alzheimer’s disease
by: Najem, Dema
Published: (2014)

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Role of Insulin Signalling and Therapeutic Implications
by: Andrea Tumminia, et al.
Published: (2018-10-01)

Systemic inflammation, mild cognitive impairment and Alzheimer’s disease: findings from the PREVENT study
by: DeCarlo, Correne A.
Published: (2016)

Insulin resistance in Alzheimer disease: Is heme oxygenase-1 an Achille's heel?
by: Eugenio Barone, et al.
Published: (2015-12-01)

The brain as an insulin-sensitive metabolic organ
by: Joshua L. Milstein, et al.
Published: (2021-10-01)

Altered expression of insulin‐degrading enzyme and regulator of calcineurin in the rat intracerebral streptozotocin model and human apolipoprotein E‐ε4–associated Alzheimer's disease
by: Büşra Delikkaya, et al.
Published: (2019-12-01)

Ten Years of Research on Automatic Voice and Speech Analysis of People With Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review Article
by: Israel Martínez-Nicolás, et al.
Published: (2021-03-01)

Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease
by: Toshitaka Ochiai, et al.
Published: (2021-11-01)

Role of DWI and MRS in diagnosis of Alzheimer’s and pre-Alzheimer’s disease
by: Amina Ahmed Sultan, MD, et al.
Published: (2017-03-01)

Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
by: Jorge Berlanga-Acosta, et al.
Published: (2020-11-01)

Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review
by: Christian Benedict, et al.
Published: (2018-04-01)

Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease
by: Daisuke Tanokashira, et al.
Published: (2019-01-01)

The Link Between Tau and Insulin Signaling: Implications for Alzheimer’s Disease and Other Tauopathies
by: Rafaella Araujo Gonçalves, et al.
Published: (2019-02-01)

Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease
by: Jhana O. Hendrickx, et al.
Published: (2021-06-01)

Suppressor of Cytokine Signaling 3: Emerging Role Linking Central Insulin Resistance and Alzheimer’s Disease
by: Lan Cao, et al.
Published: (2018-06-01)

Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?
by: Grazia Daniela Femminella, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_rikh8or6i09i7pu9micdbgqiaj